Cover Image

Combination treatment of perifosine and valsartan showed more efficiency in protecting against pressure overload induced mouse heart failure

The optimum strategy for heart failure (HF) treatment has yet to be elucidated. This study intended to test the benefit of a combination of valsartan (VAL) and perifosine (PER), a specific AKT inhibitor, in protecting against pressure overload induced mouse HF. Mouse were subjected to aortic banding...

Full description

Saved in:

Bibliographic Details
Main Authors:	Wen-jing Li (Author), Hai-han Liao (Author), Hong Feng (Author), Zi-ying Zhou (Author), Shan-qi Mou (Author), Nan Zhang (Author), Hai-ming Wu (Author), Hao Xia (Author), Qi-zhu Tang (Author)
Format:	Book
Published:	Elsevier, 2020-07-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Knockout of AMPKα2 Blocked the Protection of Sestrin2 Overexpression Against Cardiac Hypertrophy Induced by Pressure Overload
by: Nan Zhang, et al.
Published: (2021)

Sacubitril/Valsartan Improves Left Atrial and Left Atrial Appendage Function in Patients With Atrial Fibrillation and in Pressure Overload-Induced Mice
by: Ya Suo, et al.
Published: (2019)

Atrioventricular node dysfunction in pressure overload-induced heart failure-Involvement of the immune system and transcriptomic remodelling
by: Claire Wilson, et al.
Published: (2023)

Maslinic acid protects against pressure overload-induced cardiac hypertrophy in mice
by: Yan-Ling Liu, et al.
Published: (2018)

The effects of dipeptidyl peptidase-4 on cardiac fibrosis in pressure overload-induced heart failure
by: Masanori Hirose, et al.
Published: (2017)

An Insight Into Intestinal Microbiota of Spontaneously Hypertensive Rats After Valsartan Administration
by: Ying-Zi Qi, et al.
Published: (2021)

EFFECT OF SACUBITRIL/VALSARTAN ON NATRIURESIS, DIURESIS AND BLOOD PRESSURE IN HYPERTENSIVE PATIENTS
by: Zh. D. Kobalava, et al.
Published: (2017)

Clinical utility of valsartan in treatment of children and adolescents with high blood pressure
by: Kaushik M, et al.
Published: (2011)

Shen’ge Formula Protects Cardiac Function in Rats with Pressure Overload-Induced Heart Failure
by: Qiu B, et al.
Published: (2024)

Liquiritin Attenuates Lipopolysaccharides-Induced Cardiomyocyte Injury via an AMP-Activated Protein Kinase-Dependent Signaling Pathway
by: Shan-Qi Mou, et al.
Published: (2021)

Histone methyltransferase MLL4 protects against pressure overload-induced heart failure via a THBS4-mediated protection in ER stress
by: Xiang-Min Meng, et al.
Published: (2024)

A Novel Alginate-Based Delivery System for the Prevention and Treatment of Pressure-Overload Induced Heart Failure
by: Ambrish Kumar, et al.
Published: (2021)

Signaling pathway-focused gene expression profiling in pressure overloaded hearts
by: Marco Musumeci, et al.
Published: (2011)

Upregulation of Phospholipase D Expression and Activation in Ventricular Pressure-Overload Hypertrophy
by: Ali A. Peivandi, et al.
Published: (2005)

Cardiac sympathetic overdrive, M2 macrophage activation and fibroblast heterogeneity are associated with cardiac remodeling in a chronic pressure overload rat model of HFpEF
by: Fengjiao Sun, et al.
Published: (2024)

Signaling via the Interleukin-10 Receptor Attenuates Cardiac Hypertrophy in Mice During Pressure Overload, but not Isoproterenol Infusion
by: Nicholas Stafford, et al.
Published: (2020)

Potential Nephrotoxicity of Lisinopril and Valsartan on Patients with Congestive Heart Failure
by: Sarini Pani, et al.
Published: (2017)

Ganoderma lucidum polysaccharides attenuates pressure-overload-induced pathological cardiac hypertrophy
by: Changlin Zhen, et al.
Published: (2023)

USP38 exacerbates pressure overload-induced left ventricular electrical remodeling
by: Yucheng Pan, et al.
Published: (2024)

Efficacy, Safety and Tolerability of Valsartan and Hydrochlorothiazide Compared to Valsartan and Amlodipine in Stage 2 Hypertension
by: Abdul karim, et al.
Published: (2022)

The effect of fixed-dose combination of valsartan and amlodipine on nighttime blood pressure in patients with non-dipper hypertension
by: Doğan Erdoğan, et al.
Published: (2016)

The Efficacy and Safety of Sacubitril/Valsartan in Heart Failure Patients: A Review
by: Rui Zhang MD, PhD, et al.
Published: (2022)

Cardiovascular Outcomes with Sacubitril-Valsartan in Heart Failure: Emerging Clinical Data
by: Cuthbert JJ, et al.
Published: (2020)

Glycative stress inhibits hypertrophy and impairs cell membrane integrity in overloaded mouse skeletal muscle
by: Tatsuro Egawa, et al.
Published: (2024)

Human Adipose Mesenchymal Stem Cells Show More Efficient Angiogenesis Promotion on Endothelial Colony-Forming Cells than Umbilical Cord and Endometrium
by: Haiyuan Lu, et al.
Published: (2018)

Different chronotherapeutic effects of valsartan and olmesartan in non-dipper hypertensive patients during valsartan treatment at morning
by: Kentaro Ushijima, et al.
Published: (2015)

Sacubitril/Valsartan versus enalapril in nonischemic heart failure in Paradigm-Hf trial
by: Mohammed Habib
Published: (2018)

Sacubitril with valsartan, a modern pharmacotherapy in heart failure - a literature review
by: Bartosz Sadłowski, et al.
Published: (2024)

Iron-overload-induced ferroptosis in mouse cerebral toxoplasmosis promotes brain injury and could be inhibited by Deferiprone.
by: Chong Wang, et al.
Published: (2023)

New Progress in the Molecular Regulations and Therapeutic Applications in Cardiac Oxidative Damage Caused by Pressure Overload
by: Xiaomeng Shi, et al.
Published: (2022)

Higher Preoperative Endometrial Cancer Risk Showed More Advanced Stage
by: Jasmine Iskandar, et al.
Published: (2014)

A critical appraisal of the clinical effectiveness of a fixed combination of valsartan, amlodipine, and hydrochlorothiazide in achieving blood pressure goals
by: Cheryl L Laffer, et al.
Published: (2011)

Prenatal diagnosis of congenital lobar fluid overload
by: Pei-Shan Tsai, et al.
Published: (2017)

Comparison of the effects of deferasirox, deferoxamine, and combination of deferasirox and deferoxamine on an aplastic anemia mouse model complicated with iron overload
by: Wu D, et al.
Published: (2018)

An Efficient Method for the Isolation and Cultivation of Hypothalamic Neural Stem/Progenitor Cells From Mouse Embryos
by: Yichao Ou, et al.
Published: (2022)

Dapagliflozin versus sacubitril-valsartan for heart failure with mildly reduced or preserved ejection fraction
by: Ronen Arbel, et al.
Published: (2024)

Cost-Effectiveness Analysis of Sacubitril/Valsartan Compared to Enalapril for Heart Failure Patients in Indonesia
by: Zakiyah N, et al.
Published: (2021)

Spotlight on valsartan–sacubitril fixed-dose combination for heart failure: the evidence to date
by: Vilela-Martin JF
Published: (2016)

Up-Titration of Sacubitril/Valsartan Among Patients With Heart Failure and Preserved Ejection Fraction
by: Koichiro Matsumura MD, et al.
Published: (2023)

A comparison between Captopril, Valsartan, Carvedilol and Conventional therapy in the treatment of heart failure
by: Al-Mousilly M. Maiada
Published: (2005)